首页> 外文期刊>Archives of Gerontology and Geriatrics: An International Journal Integrating Experimental, Clinical and Social Studies on Ageing >Low patient compliance--a major negative factor in achieving vitamin D adequacy in elderly hip fracture patients supplemented with 800IU of vitamin D3 daily.
【24h】

Low patient compliance--a major negative factor in achieving vitamin D adequacy in elderly hip fracture patients supplemented with 800IU of vitamin D3 daily.

机译:患者依从性低-每天补充800IU维生素D3的老年髋部骨折患者获得维生素D充足的主要不利因素。

获取原文
获取原文并翻译 | 示例
           

摘要

Achievement of adequate vitamin D3 level is crucial for the treatment of hip fracture patients. Currently used vitamin D3 supplementation in Israel ranges between 200 and 800IU/day. The study objectives were to evaluate the effects of 800IU/day vitamin D3 and 1.200mg of calcium carbonate supplementation to achieve adequate vitamin D3 level of 30ng/ml in elderly hip fracture patients. One hundred and twenty-two elderly patients after surgical hip fracture correction aged 73.0+/-9.5, who were enrolled in a post-surgical treatment program (PSTP). The patients received 800IU of vitamin D3 and 1.200mg of calcium carbonate daily. Serum 25(OH)D and plasma PTH levels were assessed during initial hospital stay and at quarterly follow-up visits for 2 years. At baseline, 120 patients (98.4%) had 25(OH)D serum level <30ng/ml. Forty-two patients (34.4%) had 25(OH)D serum level <10ng/ml and these were considered as vitamin D(3) deficient. After 3 months, 29 patients (23.8%) were fully adherent to the supplement, 32 were (26.2%) partially adherent. The dropout rate at 1 year was 55.7%. The major reason for the discontinuation of participation was non-compliance. We conclude that the majority of elderly hip fracture patients had inadequate 25(OH)D serum levels. Compliance with calcium and vitamin D3 supplements was extremely low. An adequate vitamin D status was not achieved with daily vitamin D3 supplementation of 800IU. Supplementation strategies using a periodic single high dose of vitamin D3 might be more appropriate and should be considered in these patients.
机译:达到适当的维生素D3水平对于治疗髋部骨折患者至关重要。以色列目前使用的维生素D3补充剂介于200至800IU /天之间。研究目的是评估800IU /天的维生素D3和1.200mg碳酸钙的补充作用,以使老年髋部骨折患者的维生素D3水平达到30ng / ml。接受手术髋部骨折矫正的122例老年患者年龄为73.0 +/- 9.5,参加了术后治疗计划(PSTP)。患者每天接受800IU维生素D3和1.200mg碳酸钙。在初次住院期间以及在2年的季度随访中评估了血清25(OH)D和血浆PTH水平。基线时,有120名患者(98.4%)的25(OH)D血清水平<30ng / ml。 42名患者(34.4%)的25(OH)D血清水平<10ng / ml,被认为是维生素D(3)缺乏症。 3个月后,有29名患者(23.8%)完全依从补品,其中32名(26.2%)部分依从。 1年的辍学率为55.7%。终止参与的主要原因是违规。我们得出的结论是,大多数老年髋部骨折患者的血清25(OH)D水平不足。对钙和维生素D3补充剂的依从性极低。每天补充800IU的维生素D3不能达到足够的维生素D状态。使用定期单次高剂量维生素D3的补充策略可能更合适,应在这些患者中考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号